Company intelligence / Profile preview

Polysciences

Warrington, Pennsylvania, United States

Ownership: Private
Employees: ~185
Development stage: Other

Overview

Polysciences is a commercial-stage manufacturer providing specialty and fine chemicals, reagents, monomers, polymers, and microspheres for research, medical devices, diagnostics, and drug delivery. The company is not developing therapeutics directly and thus does not have traditional clinical trial results. It also recently launched Kyfora Bio (2024) for bioprocessing solutions and expanded its lab capabilities.

Modalities: Small moleculePolymer-drug conjugate therapyMicrospheresRecombinant proteinDeviceBiologic
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Polysciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polysciences.

Explore the full profile